O'Byrne Jason 4
4 · Caribou Biosciences, Inc. · Filed Feb 8, 2022
Insider Transaction Report
Form 4
O'Byrne Jason
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-02-08$4.11/sh+24,336$100,021→ 24,336 total - Exercise/Conversion
Option to purchase Common Stock
2022-02-08−24,336→ 412,865 totalExercise: $4.11Exp: 2031-03-29→ Common Stock (24,336 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to this option vested on February 8, 2022 and an additional 1/48th of the aggregate number of shares subject to the option will vest on the corresponding day of each month thereafter until the option is fully vested on February 8, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates.